Our business model is both proven and simple. Upon discovery, we patent the technology, validate the test, and license the test to a global partner for manufacturing, sales & marketing, distribution, and laboratory processing. Our tests can be developed on a number of different platforms; hence, we have no limitations in the partners we are able to attract. Furthermore, competition in the mtDNA research space is limited, leaving Genesis with significant opportunities to take advantage of the sensitivity of mtDNA molecular diagnostic tests and the low cost, highly automated processing advantages over other forms of nuclear DNA and RNA tests.

Furthermore, our discovery technology and library of proprietary mitochondrial associated molecules has the potential to extend beyond the clinical diagnostic market and into the development and commercialization of:

Broad applications in diagnostic imaging through proprietary mitochondrial “signal molecules”
Therapeutic targets based on molecules which disrupt metabolic and gene signaling pathways
Drug discoveries by highlighting currently unknown pathways through the use of our novel, mtDNA based molecules, as well as pathways which avoid drug induced mitochondrial toxicity
Patient stratifications based on genetic predisposition or tumor aggression or expected therapy response, with expanded opportunities to regularly monitor those patients and their outcomes

Leveraging the vast opportunities associated with our world leading, proprietary, market-disruptive technology requires discipline. Similarly, we are disciplined in our Partner Selection and Alliance Management processes in order to drive effective, efficient relationships and, ultimately, corporate and partner value.

Partner Selection

Fit is critical to both Genesis and its partners. Therefore, we use the following criteria to evaluate strategic corporate fit with our business model:

Global reach and power.
Corporate strategy.
Market position.
Alliance track record.
Product development effectiveness.

Alliance Management

Our model to translate our expertise and technology into business value is:

Develop a shared vision of success.
Prove technical value and develop executive value proposition.
Form strategic alliance.
Implement and monitor alliance metrics.

Alliance Fit by Product

Our products are multi-dimensional and are applicable to diverse industries:

PRODUCT	PARTNER FIT BY INDUSTRY
skinphysical® & DNA•care™	Organizations driving value in skin and sun care through innovation such as : Consumer & packaged goods manufacturers. Specialty chemical ingredients suppliers (UV Filters / absorbers) Dermatology supply manufacturers
BIOPSY+™	Organizations focused on the early diagnosis and treatment of cancer such as: Pharmaceutical Diagnostics Reference labs

Strategic Relationships

Partner Selection

Alliance Management

Alliance Fit by Product

Partner with Confidence